Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05563857 · ClinicalTrials.gov registry record · NA
Viome Nutritional Programs to Improve Clinical Outcomes for Mental Health Conditions
A NA study of Depression and Anxiety, sponsored by Viome.
- Active
- Registry status
- NA
- Development phase
- 150
- Enrollment target
- 1
- Study location
NCT05563857: Active NA study of Depression and Anxiety, sponsored by Viome.
NCT05563857 is a NA study of Depression and Anxiety that is active but no longer recruiting, run by Viome. The registered enrollment target is 150 participants, below the 786-participant average among 679 other Depression trials with a reported enrollment target (81% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05563857, a NA study of Depression and Anxiety, is active but no longer recruiting, sponsored by Viome.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 150 participants
- Enrollment target
- 1
- Study location
Study Summary
US residents who have mental health issues sign the informed consent form and are screened and enrolled for this study. Participants who are enrolled complete a survey upon enrollment and are randomized into one of three arms. This study is direct to participant and will NOT utilize clinical sites.
Conditions Studied
Interventions
- COMBINATION_PRODUCT VIOME Precision Nutrition Program
- DIETARY_SUPPLEMENT VIOME-designed condition-based supplements
Study Locations (1)
Washington
- Viome Life Sciences - Bothell
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 150 participants |
| Start Date | 2022-10-19 |
| Est. Completion | 2025-12 |
| Phase | NA |
What the registry record for NCT05563857 still lists
NCT05563857 is an interventional study that assigns participants to a tested intervention. The registered 150 participants enrollment target is mid-sized for trials with a published cap, below the 786-participant average among 679 other Depression trials with a reported enrollment target (81% lower).
The record links to 3 conditions, with Depression appearing as the primary indexed condition, and to 2 interventions - of which VIOME Precision Nutrition Program is the first listed.
NCT05563857 reports a single indexed study location in Washington.
Frequently Asked Questions
What is clinical trial NCT05563857 about?
NCT05563857 is a clinical study titled "Viome Nutritional Programs to Improve Clinical Outcomes for Mental Health Conditions". US residents who have mental health issues sign the informed consent form and are screened and enrolled for this study. Participants who are enrolled complete a survey upon enrollment and are randomized into one of three arms. This study is direct to participant and will NOT utilize clinical sites.
What is the current status of trial NCT05563857?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 150 participants. The study started on 2022-10-19. Estimated completion is 2025-12.
What conditions does trial NCT05563857 study?
This clinical trial studies the following conditions: Depression, Anxiety, Mental Health.
What interventions are being tested in trial NCT05563857?
The interventions under investigation include: VIOME Precision Nutrition Program (COMBINATION_PRODUCT), VIOME-designed condition-based supplements (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT05563857?
This trial is sponsored by Viome, which has 18 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05563857 being conducted?
This trial has 1 study location across Washington. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Depression
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05563857's enrollment target sits among peer trials
150 249th of 679 higher than 416 of 679 other Depression trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Depression trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Reaching Out to Distressed Medical Residents, Fellows and Faculty
RECRUITING · NA
-
IMPACT (IMproving Proactive Approaches for Cancer Survivors' Mental Health Treatment)
RECRUITING · NA
-
Cold and Heat Investigation to Lower Levels of Depression
RECRUITING · NA
-
Dosing rTMS for Depression Post-SCI
RECRUITING · NA
-
Exploring Virtual Reality Adventure Training Exergaming
RECRUITING · NA
-
Brief Interventions for Coping with Distress
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00412594 · 150 participants · Phase 2
Cladribine and Rituximab in Treating Patients With Hairy Cell Leukemia
- NCT01484730 · 150 participants
A Pilot Study to Evaluate Multi-Spectral and Laser Speckle Imaging and Multiphoton Microscopy During Vascular Occlusion
- NCT01985919 · 150 participants
Protocol for Facilitating the Acquisition of Research Bone Marrow and Blood Samples
- NCT02016248 · 150 participants · NA
SBRT Boost for Unfavorable Prostate Cancer'
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT06358040 · started 2026-10 · NA
Opioid Dispenser for Microdiscectomy/Laminectomy